PMC

TDP-43 Acetylation at the Neuroimmune Interface: A Hypothesis-Driven Framework for Peripheral Inflammatory Stratotypes in ALS Read the publication Pharmaceutical Management Company (PMC) ltd. is pleased to share the publication of a new scientific article in the international Journal Neurochemical Research. The review explores an emerging and highly relevant topic in neurodegenerative research: the potential role…

PMC is pleased to share its recent scientific publication in Planta Medica: “Borassus aethiopum in Immunometabolic Pharmacology: Linking Phytochemistry, Oxidative Stress and Cytokine Signalling” The publication explores the role of complex plant-based matrices as potential multi-target modulators within the immunometabolic framework, with a specific focus on the interplay between oxidative stress, cytokine signalling and chronic low-grade inflammation. Cardiometabolic…

This month, PMC has been recognised within the ITRN Reproducibility Awards promoted by the Italian Reproducibility Network. This recognition highlights contributions supporting reproducibility, transparency and Open Science practices, which are essential to strengthening the quality, reliability and impact of scientific research. PMC expresses its sincere gratitude to the Italian Reproducibility Network for this recognition and for its continued commitment to…

At PMC, we believe that ethical integrity is the foundation of every successful clinical development program. In a landscape where regulatory frameworks, scientific innovation, and patient safety intersect, maintaining the highest ethical standards is not optional—it is essential. A recent publication in Medicine, Science and the Law (SAGE Publishing) titled: “Informed consent in clinical research: Medico-legal standards, ethical challenges…